医学
心肌炎
免疫学
干扰素
自身免疫性疾病
内科学
抗体
作者
Urs Eriksson,Michael Odo Kurrer,Roland M Bingisser,Hans‐Pietro Eugster,Parvin Saremaslani,Ferenc Folláth,Stephan C. U. Marsch,U. Widmer
出处
期刊:Circulation
[Lippincott Williams & Wilkins]
日期:2001-01-02
卷期号:103 (1): 18-21
被引量:114
标识
DOI:10.1161/01.cir.103.1.18
摘要
BACKGROUND: Interferon-gamma (IFN-gamma) is an essential cytokine in the regulation of inflammatory responses in autoimmune diseases. Little is known about its role in inflammatory heart disease. METHODS AND RESULTS: We showed that IFN-gamma receptor-deficient mice (IFN-gammaR(-/-)) on a BALB/c background immunized with a peptide derived from cardiac alpha-myosin heavy chain develop severe myocarditis with high mortality. Although myocarditis subsided in wild-type mice after 3 weeks, IFN-gammaR(-/-) mice showed persistent disease. The persistent inflammation was accompanied by vigorous in vitro CD4 T-cell responses and impaired inducible nitric oxide synthase expression, together with evidence of impaired nitric oxide production in IFN-gammaR(-/-) hearts. Treatment of wild-type mice with the nitric oxide synthetase inhibitor N:-nitro-l-arginine-methyl-ester enhanced in vitro CD4 T-cell proliferation and prevented healing of myocarditis. CONCLUSIONS: Our data provide evidence that IFN-gamma protects mice from lethal autoimmune myocarditis by inducing the expression of inducible nitric oxide synthase followed by the downregulation of T-cell responses.
科研通智能强力驱动
Strongly Powered by AbleSci AI